439 related articles for article (PubMed ID: 23807837)
1. Preparation and evaluation of a multimodal minoxidil microemulsion versus minoxidil alone in the treatment of androgenic alopecia of mixed etiology: a pilot study.
Sakr FM; Gado AM; Mohammed HR; Adam AN
Drug Des Devel Ther; 2013; 7():413-23. PubMed ID: 23807837
[TBL] [Abstract][Full Text] [Related]
2. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD
J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
[TBL] [Abstract][Full Text] [Related]
3. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
Olsen EA; Dunlap FE; Funicella T; Koperski JA; Swinehart JM; Tschen EH; Trancik RJ
J Am Acad Dermatol; 2002 Sep; 47(3):377-85. PubMed ID: 12196747
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study.
Blume-Peytavi U; Issiakhem Z; Gautier S; Kottner J; Wigger-Alberti W; Fischer T; Hoffmann R; Tonner F; Bouroubi A; Voisard JJ
J Cosmet Dermatol; 2019 Feb; 18(1):215-220. PubMed ID: 29659116
[TBL] [Abstract][Full Text] [Related]
5. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women.
Blume-Peytavi U; Hillmann K; Dietz E; Canfield D; Garcia Bartels N
J Am Acad Dermatol; 2011 Dec; 65(6):1126-1134.e2. PubMed ID: 21700360
[TBL] [Abstract][Full Text] [Related]
6. Use of topical minoxidil therapy for androgenetic alopecia in women.
Jacobs JP; Szpunar CA; Warner ML
Int J Dermatol; 1993 Oct; 32(10):758-62. PubMed ID: 8225725
[TBL] [Abstract][Full Text] [Related]
7. Topical minoxidil for hair regrowth.
Vanderveen EE; Ellis CN; Kang S; Case P; Headington JT; Voorhees JJ; Swanson NA
J Am Acad Dermatol; 1984 Sep; 11(3):416-21. PubMed ID: 6384289
[TBL] [Abstract][Full Text] [Related]
8. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial.
Penha MA; Miot HA; Kasprzak M; Müller Ramos P
JAMA Dermatol; 2024 Jun; 160(6):600-605. PubMed ID: 38598226
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial.
Shin HS; Won CH; Lee SH; Kwon OS; Kim KH; Eun HC
Am J Clin Dermatol; 2007; 8(5):285-90. PubMed ID: 17902730
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
[TBL] [Abstract][Full Text] [Related]
11. A Phase III, Multicenter, Parallel-Design Clinical Trial to Compare the Efficacy and Safety of 5% Minoxidil Foam Versus Vehicle in Women With Female Pattern Hair Loss.
Bergfeld W; Washenik K; Callender V; Zhang P; Quiza C; Doshi U; Blume-Peytavi U
J Drugs Dermatol; 2016 Jul; 15(7):874-81. PubMed ID: 27391639
[TBL] [Abstract][Full Text] [Related]
12. Similar response patterns to topical minoxidil foam 5% in frontal and vertex scalp of men with androgenetic alopecia: a microarray analysis.
Mirmirani P; Consolo M; Oyetakin-White P; Baron E; Leahy P; Karnik P
Br J Dermatol; 2015 Jun; 172(6):1555-1561. PubMed ID: 25204361
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Minoxidil 5% Foam in Combination With a Botanical Hair Solution in Men With Androgenic Alopecia.
Keaney TC; Pham H; von Grote E; Meckfessel MH
J Drugs Dermatol; 2016 Apr; 15(4):406-12. PubMed ID: 27050695
[TBL] [Abstract][Full Text] [Related]
14. A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia.
Suchonwanit P; Rojhirunsakool S; Khunkhet S
Lasers Med Sci; 2019 Dec; 34(9):1857-1864. PubMed ID: 30982177
[TBL] [Abstract][Full Text] [Related]
15. A Single-Centre, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Investigate the Efficacy and Safety of Minoxidil Topical Foam in Frontotemporal and Vertex Androgenetic Alopecia in Men.
Hillmann K; Garcia Bartels N; Kottner J; Stroux A; Canfield D; Blume-Peytavi U
Skin Pharmacol Physiol; 2015; 28(5):236-44. PubMed ID: 25765348
[TBL] [Abstract][Full Text] [Related]
16. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.
Olsen EA; Whiting D; Bergfeld W; Miller J; Hordinsky M; Wanser R; Zhang P; Kohut B
J Am Acad Dermatol; 2007 Nov; 57(5):767-74. PubMed ID: 17761356
[TBL] [Abstract][Full Text] [Related]
17. Treatment of female androgenetic alopecia with minoxidil 2%.
Whiting DA; Jacobson C
Int J Dermatol; 1992 Nov; 31(11):800-4. PubMed ID: 1428436
[TBL] [Abstract][Full Text] [Related]
18. Curcuma aeruginosa, a novel botanically derived 5α-reductase inhibitor in the treatment of male-pattern baldness: a multicenter, randomized, double-blind, placebo-controlled study.
Pumthong G; Asawanonda P; Varothai S; Jariyasethavong V; Triwongwaranat D; Suthipinittharm P; Ingkaninan K; Leelapornpisit P; Waranuch N
J Dermatolog Treat; 2012 Oct; 23(5):385-92. PubMed ID: 21756154
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study.
Suchonwanit P; Iamsumang W; Rojhirunsakool S
Am J Clin Dermatol; 2019 Feb; 20(1):147-153. PubMed ID: 30206824
[TBL] [Abstract][Full Text] [Related]
20. Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment.
Price VH; Menefee E; Strauss PC
J Am Acad Dermatol; 1999 Nov; 41(5 Pt 1):717-21. PubMed ID: 10534633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]